Protara Therapeutics

New York, United States

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

Dec 2025

Post-IPO Equity

Biotechnology Health Care Therapeutics

Top Investors

RA Capital ManagementCatalio Capital ManagementArmistice CapitalRed Cedar VenturesWoodline Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Protara Therapeutics

Who are Protara Therapeutics's investors?

Protara Therapeutics's investors include RA Capital Management, Catalio Capital Management, Armistice Capital, Red Cedar Ventures, Woodline Partners.

Where is Protara Therapeutics headquartered?

Protara Therapeutics is headquartered in New York, United States.

What does Protara Therapeutics do?

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

What stage is Protara Therapeutics at?

Protara Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 4, 2025.

MLA

"Protara Therapeutics — Funding & Investors." VCBacked, December 4, 2025, https://www.vcbacked.co/company/protara-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). Protara Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/protara-therapeutics

Wikipedia (cite web)

{{cite web |title=Protara Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/protara-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 4, 2025.